Table 4.
Marginal estimates of vaccine acceptance (and 95% confidence intervals) across different vaccine profiles as predicted by logistic regression models, stratified by demographic characteristics in six countries.
| 50% VE, 20% Fever Risk |
50% VE, 5% Fever Risk |
95% VE, 20% Fever Risk |
95% VE, 5% Fever Risk |
p-Value a | |
|---|---|---|---|---|---|
| Overall | 75% (63%, 80%) | 76% (66%, 83%) | 89% (81%, 94%) | 88% (81%, 92%) | |
| By wave | <0.0001 | ||||
| Aug 2020 | 77% (68%, 84%) | 78% (68%, 85%) | 89% (82%, 94%) | 88% (80%, 93%) | |
| Nov 2020 | 71% (56%, 82%) | 71% (59%, 81%) | 86% (78%, 92%) | 87% (80%, 91%) | |
| By age | <0.0001 | ||||
| 18–34 | 76% (68%, 82%) | 80% (76%, 84%) | 87% (76%, 93%) | 88% (81%, 93%) | |
| 35–54 | 73% (62%, 82%) | 74% (59%, 85%) | 88% (80%, 93%) | 87% (80%, 92%) | |
| ≥55 | 72% (51%, 86%) | 67% (54%, 77%) | 90% (84%, 94%) | 85% (78%, 90%) | |
| By gender | 0.1864 | ||||
| Male | 73% (60%, 83%) | 75% (60%, 85%) | 87% (76%, 94%) | 85% (74%, 92%) | |
| Female | 75% (64%, 84%) | 75% (67%, 80%) | 88% (83%, 92%) | 89% (85%, 92%) | |
| By income | <0.0001 | ||||
| <$2000 equivalent | 75% (64%, 83%) | 75% (64%, 84%) | 86% (75%, 93%) | 83% (72%, 90%) | |
| ≥$2000 equivalent | 74% (60%, 84%) | 74% (63%, 83%) | 89% (81%, 94%) | 89% (82%, 94%) | |
| By vaccine hesitancy | <0.0001 | ||||
| No | 84% (77%, 89%) | 85% (76%, 90%) | 95% (92%, 97%) | 96% (92%, 98%) | |
| Yes | 61% (47%, 73%) | 64% (53%, 74%) | 78% (66%, 87%) | 75% (64%, 84%) |
Notes: VE, vaccine effectiveness. a Interaction between vaccine profile and demographic variable.